SSTR2 Receptor Expression Increased in Recurrent and Metastatic Hurthle Cell Carcinoma: Implications for Treatment

被引:0
|
作者
Gonzalez, Manuel Lora [1 ]
Wang, Dezhi [1 ]
Guenter, Rachael [1 ]
Zheng-Pywell, Rui [1 ]
Rose, J. Bart [1 ]
Jaskula-Sztul, Renata [1 ]
Lloyd, Ricardo [2 ]
Lin, Diana [1 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Wisconsin, Madison, WI USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
823
引用
收藏
页码:887 / 887
页数:1
相关论文
共 50 条
  • [31] Epigenetic modulation of SSTR2 expression provides the potential to broaden PEN-221 treatment population
    Perino, Samantha
    Quinn, James
    Freda, Jessica
    White, Brian
    Bailey, Scott
    Bhatia, Viren
    Sweryda-Krawiec, Beata
    Bilodeau, Mark
    Bloss, Jeffrey D.
    Whalen, Kerry
    Wooster, Richard
    CANCER RESEARCH, 2019, 79 (13)
  • [32] TREATMENT OF ADVANCED HEPATOCARCINOMA (HCC) WITH LONG ACTING OCTREOTIDE IN PATIENTS WITH TUMORAL EXPRESSION OF SSTR2 RECEPTORS
    De Santis, A.
    Trapani, S.
    Gigliotti, F.
    Cristofari, F.
    Giubilo, F.
    Iegri, C.
    Massa, R.
    Muda, A. Onetti
    Attili, A. F.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S34 - S35
  • [33] Discovery and SAR Studies of Orally Active Somatostatin Receptor Subtype-2 (SSTR2) Agonists for the Treatment of Acromegaly
    Ishida, Akiharu
    Tajima, Yohei
    Okabe, Yasuyuki
    Matsushita, Takeshi
    Sekiguchi, Tetsuya
    Imaide, Satomi
    Nomura, Yoshinori
    Tanaka, Motoyuki
    Nojima, Shoji
    Yoshida, Atsushi
    Iyoda, Yoko
    Aoki, Shohei
    Nishio, Takuya
    Komagata, Tatsuya
    Iwaki, Masanori
    Shono, Tomoyuki
    Naganawa, Atsushi
    Imagawa, Akira
    ACS CHEMICAL NEUROSCIENCE, 2020, 11 (10): : 1482 - 1494
  • [34] Expression and localization of somatostatin receptor types 3, 4 and 5 in the wild-type, SSTR1 and SSTR1/SSTR2 knockout mouse cochlea
    Vesna Radojevic
    Daniel Bodmer
    Cell and Tissue Research, 2014, 358 : 717 - 727
  • [35] EXPRESSION AND LOCALIZATION OF SOMATOSTATIN RECEPTOR SSTR1, SSTR2, AND SSTR3 MESSENGER-RNAS IN PRIMARY HUMAN TUMORS USING IN-SITU HYBRIDIZATION
    REUBI, JC
    SCHAER, JC
    WASER, B
    MENGOD, G
    CANCER RESEARCH, 1994, 54 (13) : 3455 - 3459
  • [36] STIMULATION OF TYROSINE PHOSPHATASE AND INHIBITION OF CELL-PROLIFERATION BY SOMATOSTATIN ANALOGS - MEDIATION BY HUMAN SOMATOSTATIN RECEPTOR SUBTYPES SSTR1 AND SSTR2
    BUSCAIL, L
    DELESQUE, N
    ESTEVE, JP
    SAINTLAURENT, N
    PRATS, H
    CLERC, P
    ROBBERECHT, P
    BELL, GI
    LIEBOW, C
    SCHALLY, AV
    VAYSSE, N
    SUSINI, C
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2315 - 2319
  • [37] The Value of PET/CT in Particle Therapy Planning of Various Tumors with SSTR2 Receptor Expression: Comparative Interobserver Study
    Luetgendorf-Caucig, Carola
    Wieland, Patricia
    Hug, Eugen
    Flechl, Birgit
    Tubin, Slavisa
    Galalae, Razvan
    Georg, Petra
    Fossati, Piero
    Mumot, Marta
    Harrabi, Semi
    Pradler, Irina
    Pelak, Maciej J.
    CANCERS, 2024, 16 (10)
  • [38] Docetaxel in combination with octreotide shows synergistic apoptotic effect by increasing SSTR2 and SSTR5 expression levels in prostate and breast cancer cell lines
    Karaca, Burcak
    Degirmenci, Mustafa
    Ozveren, Ahmet
    Atmaca, Harika
    Bozkurt, Emir
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (06) : 1273 - 1280
  • [39] Somatostatin receptor (SSTR) expression and function in normal and leukaemic T-cells.: Evidence for selective effects on adhesion to extracellular matrix components via SSTR2 and/or 3
    Talme, T
    Ivanoff, J
    Hägglund, M
    Van Neerven, RJJ
    Ivanoff, A
    Sundqvist, KG
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 125 (01): : 71 - 79
  • [40] Combined Treatment with 177Lu-DOTATOC and Histone Deacetylase Inhibitor s on SSTR2 Expression and Uptake in in vivo
    Bakr, H.
    Al-Awar, A.
    Forssell-Aronsson, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S334 - S334